热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Pacific Blue™ anti-mouse CD4 Antibody
产品名称：
Pacific Blue™ anti-mouse CD4 Antibody
产品类别：
抗体
产品编号：
100534
产品应用：
100534
[价格]
规格 价格 库存
25µg ￥ 1316 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
BALB/c mouse thymocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with Pacific Blue? under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤1.0 ?g per 106 cells in 100 ?l volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Pacific Blue? has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue? conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Violet Laser (405 nm)
Application Notes

The RM4-5 antibody blocks the binding of GK1.5 antibody and H129.19 antibody to CD4+ T cells, but not RM4-4 antibody. Additional reported applications (for the relevant formats) include: blocking of ligand binding, in vivo depletion of CD4+ cells1, and immunohistochemistry of acetone-fixed frozen tissue sections2,3,11 and paraffin-embedded sections11. Clone RM4-5 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. Instead, acetone frozen or zinc-fixed paraffin sections are recommended. The Ultra-LEAF? Purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 100575 and 100576).

Application References

(PubMed link indicates BioLegend citation)
  1. Kruisbeek AM. 1991. In Curr. Protocols Immunol. pp. 4.1.1-4.1.5. (Block, Deplete)
  2. Nitta H, et al. 1997. Cell Vision 4:73. (IHC)
  3. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045.
  4. Muraille E, et al. 2003. Infect. Immun. 71:2704. (IHC)
  5. León-Ponte M, et al. 2007. Blood 109:3139. (FC)
  6. Bourdeau A, et al. 2007. Blood doi:10.1182/blood-2006-08-044370. (FC)
  7. Matsumoto M, et al. 2007.J. Immunol.178:2499. PubMed
  8. Shigeta A, et al. 2008. Blood 112:4915. PubMed
  9. Zaborsky N, et al. 2010. J. Immunol. 184:725. PubMed
  10. Rodrigues-Manzanet R, et al. 2010. P. Natl Acad Sci USA 107:8706. PubMed
  11. Whiteland JL, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
Product Citations
  1. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  2. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  3. Kwong Chung CK, et al. 2017. Immunology. 150:221. PubMed
  4. Jankovic D, et al. 2013. J Exp Med. 210:1899. PubMed
  5. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  6. Zhang Y, et al. 2019. Cell Res. 29:609. PubMed
  7. Her Z, et al. 2015. EMBO Mol Med. 7:24. PubMed
  8. Ooi JD, et al. 2019. Nat Commun. 10:3392. PubMed
  9. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  10. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  11. Mier-Aguilar C, et al. 2016. PLoS One. 11:e0168155. PubMed
  12. Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed
  13. Essig K et al. 2017. Immunity. 47(6):1067-1082 . PubMed
  14. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  15. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  16. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  17. Engler JB, et al. 2019. J Immunol. 203:1743. PubMed
  18. Chan YH, et al. 2019. EMBO Mol Med. 11:e10092. PubMed
  19. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  20. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  21. Marsh S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1316 - 1325. PubMed
  22. Shi LZ, et al. 2019. Cancer Immunol Res. 1.54375. PubMed
  23. An J, et al. 2022. iScience. 25:103570. PubMed
  24. Aldrich AL, et al. 2021. The Journal of Immunology. 206(4):751-765. PubMed
  25. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  26. Lu K, et al. 2015. J Leukoc Biol. 98: 301-311. PubMed
  27. Taube C, et al. 2011. PLoS One. 6:e21799. PubMed
  28. Gao J et al. 2016. Cell. 167(2):397-404 . PubMed
  29. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  30. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  31. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
  32. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  33. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  34. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  35. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  36. Xiong H, et al. 2021. Theranostics. 11:1594. PubMed
  37. Sood S, et al. 2016. J Immunol. 197: 429 - 440. PubMed
  38. Shi L, et al. 2016. Nat Commun. 7:12335. PubMed
  39. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  40. Prizant H, et al. 2021. Cell Reports. 36(6):109523. PubMed
  41. Kolev M, et al. 2020. Immunity. 52(3):513-527. PubMed
  42. Wu B, et al. 2021. Immunity. 54(2):308-323.e6. PubMed
  43. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  44. Gorman JA, et al. 2019. Front Immunol. 10:44. PubMed
  45. Ding Y, et al. 2013. J Immunol. 191:1614. PubMed
  46. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  47. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  48. O'Leary CE, et al. 2021. Curr Protoc. 1:e77. PubMed
  49. Iwata A, et al. 2017. Nat Immunol. 18:563. PubMed
  50. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  51. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
  52. Webb LM, et al. 2020. J Clin Invest. 130:1683. PubMed
  53. Gaylo‐Moynihan A et al. 2019. Immunity. 51(2):298-309 . PubMed
  54. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  55. Li H, et al. 2011. J Immunol. 186:230. PubMed
  56. Jee JJ, et al. 2022. Nat Commun. 13:18. PubMed
  57. Reguzova A, et al. 2020. Vaccines (Basel). 8:. PubMed
  58. Alterauge D, et al. 2020. Cell Rep. 33:108232. PubMed
  59. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  60. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  61. Laczkó D, et al. 2020. Immunity. 53:724. PubMed
  62. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  63. Angelou CC, et al. 2020. Frontiers in Immunology. 2.586805556. PubMed
  64. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
RRID
AB_493375 (BioLegend Cat. No. 100534) AB_493374 (BioLegend Cat. No. 100531)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线